Skip to content

    Recently Viewed

      Listening...

      Home / Latest news / Innovation /
      The Johnson & Johnson Institute: 9 facts about a program that trains 125,000 healthcare providers each year
      A photo of the Johnson & Johnson Institute in Irvine, California

      The Johnson & Johnson Institute: 9 facts about a program that trains 125,000 healthcare providers each year

      Specialty medical device training labs. An app that enables medical professionals to practice procedures via 3-D operating room simulations. Welcome to the cutting-edge Institute training program, which has 26 campuses around the world.

      Share Article
      share to

      Where do doctors and other healthcare providers go to learn about the latest innovations and procedures in medicine?

      For the past 25 years, the answer has been: the Johnson & Johnson Institute.

      Since 1992, when the first Institute opened in Cincinnati, Ohio, the company has trained and educated healthcare providers—like doctors, nurses and medical students—at various Johnson & Johnson Institutes.

      Today, there are 26 Institute locations across the globe, where healthcare professionals can do everything from learn how to use state-of-the-art medical device implants to watch top surgeons perform ear, nose and throat procedures.

      Simply put: By providing healthcare providers with the best education possible, Johnson & Johnson is paving the way for a healthier future.

      As the Institute unifies all of its operations under one umbrella this fall—the Johnson & Johnson Institute—we’re sharing some fun facts about the program’s early days and what’s in store for its future.

      Visit the Institute—virtually

      Check out the new Johnson & Johnson Institute website to learn more about how the company is educating healthcare providers.

      Institute Infographic Final

      More from Johnson & Johnson

      Health & wellness
      Illustration of three human bladders representing bladder cancer

      5 things we now know about bladder cancer

      Paradigm-shifting new therapies are helping people with the disease lead longer, more comfortable lives. For Bladder Cancer Awareness Month, learn how Johnson & Johnson is helping to change the treatment landscape.
      Innovation
      IL-23 protein structures

      What is IL-23?

      This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat autoimmune conditions such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.
      Innovation
      Male surgeon wearing blue face mask using magnifying lens during surgical procedure

      Reconnecting the meaning of these two simple words: Health&Care

      Johnson & Johnson is restoring the true meaning of healthcare by developing advanced treatments and smarter and less invasive solutions for today’s most complex diseases.
      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.